Investigating Collamer's accommodation

Article

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

The Collamer material, a proprietary pure collagen copolymer that STAAR claims is similar to the crystalline lens, is also used in the company's Visian ICL. Lenses made using Collamer have had FDA approval since 2000; the distribution of the Collamer lens's high water content, its biocompatibility and bio-adhesive properties have raised hopes that Collamer will prove a suitable material for accommodative lenses.

Phase I of the CAST study will assess the Collamer Aspheric Single Piece Lens by gathering near and distance visual acuity data. Phase II will evaluate the accommodative properties of the lens after the implementation of changes made to maximize accommodation and compare these with the accommodation data gathered in Phase I. If Phase II shows superior accommodation properties, STAAR plans to make the adjusted lens available next year, and may seek a new labelling claim from the FDA. Phase III will assess a new design of Collamer lens.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.